3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Glioblastoma
6
Rectal Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Burkitt Lymphoma
4
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Glioma
3
Astrocytoma
3
Adenocarcinoma of Lung
3
Rhabdomyosarcoma
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma, Follicular
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma
2
Breast Carcinoma In Situ
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiotherapy
×
30 days
×
Clear all
No trials found.